The modern history of blood transfusion began with Landsteiner's classic description of the A, B, and O blood groups 1). Specific typing and crossmatching techniques can now be applied with all erythrocyte antigens and have virtually eliminated major transfusion reactions due to red blood cell incompatibility.
In 1943, Loutit and Mollison found that glucose and citrate could be autoclaved together if the solution was acidified with citric acid 4). Acid-citrate-dextrose anticoagulant is now in use throughout the world and permits whole blood to be refrigerated at 4C.
Approximately 70% of the cells remain viable for 21 days following collection 5). Widespread use of ACD solution for collection and storage of blood has changed the entire scope of modern medicine. Developments in cardiac, vascular and radical cancer surgery over the past ten years would not have been possible without blood replacement therapy.
Routine use of blood transfusions and their relative freedom from major erythrocyte incompatibility reactions have lead to progressively increased demands for blood. At the Massachusetts General Hospital
Blood Bank, 50% of the blood is dispensed to patients who receive more than 5 liters 6). Transfusion of sick patients with large volumes of ACD blood frequently leads to acidosis, impaired cardiac function and bleeding. Although liquid blood has proved to be very useful, it also has major limitations. Febrile reactions due to leukocyte and platelet sensitivity are being seen with increasing frequency in recipients of multiple transfusions. Graft versus host reactions in which lymphocytes of fresh blood form antibodies against the recipient and lead to hemolytic anemia have been identified following open heart surgery.
Communicable disease-e.g. syphilis, malaria, hepatitis, and possibly leukemia-can be transmitted by This work was supported in part by the U.S. Public Health Service Grant HE-05673 from the National Heart Institute.
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Current efforts to prolong the useful storage of red blood cells by the use of citrate-phosphate-dextrose (CPD) anticoagulant or by the addition of adenine nucleotides to ACD-collected blood may help to improve the viability of the erythrocytes 7, 8) . It is unlikely, however, that either of these methods will have significant effect on the metabolic or donor-recipient problems inherent in massive whole blood transfusion. "Liquid storage methods have described by Dr. John Gibson as delayed deterioration" rather than preservation 7).
An ideal technique for blood preservation would employ cryogenic temperatures to arrest the aging of erythrocytes and cell washing to purify whole blood and reduce the number of its extraneous components.
Neither measure by itself would be as beneficial as the two combined.
Initial experiments in our laboratory were designed to study the events that take place during the slow freezing and thawing of human blood. When water freezes, intermolecular hydrogen bonding between water molecules leads to ice crystal formation. Ordinary solutes do not participate in this type of electrostatic bonding, are excluded from the water-lattice structure, and become concentrated in the small percentage of liquid water that remains in the interstices between the crystals of pure water. Concentration of solutes by freezing is illustrated diagramatically in Figure 1 .
Lovelock, in 1953, found that human erythrocytes are damaged by contact with concentrated sodium chloride solutions 9). Our studies have confirmed Lovelock's findings and have shown that both human red blood cells and platelets are damaged whenever sodium chloride concentrations exceed 0.8M. Miura has recently found that canine erythrocytes and whole perfused canine kidneys are also damaged irreversibly by salt solutions stronger than 0.6M NaCI 10). 6 of our early studies and found it to afford virtually complete protection to large volumes of human blood against hemolysis during slow freezing and thawing 1). Although blood preserved with this additive gave excellent clinical results, uncertainty regarding toxicity led us to search for methods by which the normal body constituent, glycerol, could be substituted for dimethylsulfoxide. ECA's diffuse into erythrocytes without concentration gradient, and exert no net osmotic action upon living cells. The action of ECA's and distilled water are similar in this regard. An external solute must be added to ECA solutions to maintain osmotic equilibrium. If the added solute is hypertonic, the percentage of hemolysis after storage for 24 hours at-85C. is greater than that found with similar cells frozen in isotonic media 20). Hemolysis in hyper-or isotonic media, however, does not increase with prolongation of storage in the frozen state. If the ECA solution is hypotonic, however, hemolysis in blood samples thawed after 24 hours is minimal but increases with storage at-85C.
The rate of progression of hemolysis during storage is related to the degree of cellular swelling before freezing and is maximum for cells just smaller than their critical bursting volume. The destruction of swollen erythrocytes that takes place during storage at low temperatures occurs whether NaCI, sucrose, or glucose is the solute and appears to be an osmotic rather than a specific chemical function of the additive. Hypotonic hemolysis of swollen erythrocytes during storage can explain the wide variation in reported results of long-term storage of erythrocytes in glycerol at low temperatures. The degree of success of human erythrocyte preservation is determined both by the concentration of the ECA and that of the external solute in the prefreezing medium 17).
Dr. Audrey Smith found that ECA's must be removed from thawed blood to prevent osmotic hemolysis on transfusion. Techniques that have proved effective for removal of ECA's include dilution, dialysis and serial or continuous centrifugal washing. The ECA is removed by its dilution in a large aqueous phase. Physical-chemical methods designed to separate ECA's from water (e.g. partition, precipitation or fractional distillation techniques) have all been tried and found to be ineffective. In the search for new ways to remove ECA's from thawed glycerolized blood, we studied the clumping that occurs when blood is diluted with sugar solutions. This phenomenon is seen in an intravenous tubing set whenever a blood transfusion is followed by dextrose in water.
Our studies led us to conclude that cy-globulins and red blood cells normally exist together as separate entities in plasma (Figure 3 ). In the pH range 5.2 to 6.1, however, a reversible complex is formed between ty-globulins of the plasma and lipoproteins of the red blood cell wall (Figure 4)27) . If the ionic strength of the slightly acid medium is lowered, the globulins precipitate with co-precipitation of the attached erythrocytes ( Figure 5 ). It is a fortunate coincidence that the pH of ACD blood and autoclavedd sugar solutions are optimum to promote agglomeration. Agglomerated cells may be resuspended eitherby the addition of electrolyte, breaking the y-globulin-cy-globulin bond, or by raising the pH, breaking the ty-globulin-lipoprotein bond ( Figure 6 ). The phenomenon has been called reversible agglomeration. The percentage of hemolysis of erythrocytes at different stages of processing is shown in Table I .
When frozen cells are administered as packed cells the recipient receives between 10 and 70mg. of free hemoglobin per unit. The quantity is less than that frequently found in 21-day-old ACD blood. Although the erythrocyte antigens in the Japanese population have different specificity than those listed above, the basic approach to the clinical problems of blood group antibodies could be used. To do this requires a knowledge of the statistical frequency of antibodies responsible for hemolytic reactions and the incidence of blood group genotypes in the random donor population. The concept of specific donor selection by statistical usefulness may modify the generally accepted concept of random collection for random need.
During the course of washing after thawing the anticoagulant, excess potassium and other electrolytes are removed. This purification of whole blood has proved useful in the treatment of uremic and hypocalcemic patients. No foreign protein or urticarial reactions have been encountered even in sensitized recipients.
Removal of the donors plasma suggests that the absolute amount of serum hepatitis virus carried in frozen blood might also be reduced. Clinical cases of all infectious diseases are the product of the dose of infectious agent and the resistance of the host. Reduction of the dose of virus by washing might, therefore, be reflected by a lesser incidence of serum hepatitis following transfusion with frozen blood than is seen at present with ACD blood.
No cases of homologous serum hepatitis have been encountered following administration of blood frozen by our system. The clinical series, however, is small and the attack rate of hepatitis in the Boston area is low. "Absence of cases of serum hepatitis, therefore, does not necessarily indicate a casual relationship." In any event a person anticipating surgery could have his own blood frozen for autotransfusion when needed. Autotransfusion is the only certain method for preventing homologous serum hepatitis.
White blood cells and platelets are removed during preservation of blood by freezing. The leukocytes are killed during slow freezing and thawing in the 5.0 to 5.6M glycerol. The optimum glycerol concentration for leukocyte preservation is 1.9 to 2.2M. The debris of dead white cells and platelets is removed during the washing phase after thawing.
Blood without viable white blood cells has major clinical usefulness in patients with leukoagglutinins.
In our experience, this type of patient can be given frozen blood without developing febrile reactions.
Elimination of viable histocompatibility antigens makes frozen blood of particular value for kidney homotransplant recipients, and potential recipients. We now use frozen blood routinely in this group of desperately ill patients.
At the present time frozen blood accounts for 4% of the output of the Massachusetts General Hospital Blood Bank.
SUMMARY
A method has been developed to preserve blood at cryogenic temperatures. The technique is simple, relatively inexpensive, and rests on a firm physiologic basis.
In addition to the long-term storage characteristics, the resuspended frozen blood has attributes that make it superior to ACD collected whole blood in selected clinical situations. The concept of specific donor selection by statistical usefulness may modify the general concept of random collection for random need.
